Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Jan. 16, 2026 /CNW/ -- Equity Insider News Commentary – The precision medicine sector is undergoing a ...
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T ...
A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood ...
New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...
January 15, 2026) - Nanjing Leads Biolabs Co., Ltd. (HKE: 9887) ("Leads Biolabs" or the "Company") today announced that Opamtistomig (LBL-024), its core investigational PD-L1/4-1BB bispecific antibody ...
18h
Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026
The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback